Publicacións en colaboración con investigadores/as de Pharmacoeconomics and Outcomes Research Iberia (2)

2017

  1. Cost-effectiveness and cost-utility analysis of apixaban versus dabigatran and rivaroxaban in the treatment and secondary prevention of venous thromboembolism

    Pharmacoeconomics - Spanish Research Articles, Vol. 14, Núm. 1, pp. 7-18

2016

  1. Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and Vitamin K antagonists for treatment and secondary prevention of venous thromboembolism

    Farmacia Hospitalaria, Vol. 40, Núm. 3, pp. 187-208